Teen transgender access to pubertal suppression lowers suicidality

Teen transgender access to pubertal suppression lowers suicidality

January 23, 2020 Teen transgender access to pubertal suppression lowers suicidality (HealthDay)—Access to pubertal suppression during adolescence is associated with lower odds of lifetime suicidal ideation among transgender young adults, according to a study published online Jan. 23 in Pediatrics . Jack L. Turban, M.D., from Massachusetts General Hospital in Boston, and colleagues surveyed 20,619 transgender adults (aged 18 to 36 years) to assess self-reported history of pubertal suppression during adolescence. Associations between access to pubertal suppression and adult mental health outcomes, including multiple measures of suicidality, were evaluated. The researchers found that 16.9 percent of respondents reported that they ever wanted pubertal suppression as part of their gender-related care. Of the 45.2 percent of participants assigned male sex, 2.5 percent received pubertal suppression. Those who received treatment with pubertal suppression had lower odds of lifetime suicidal ideation compared with those who wanted pubertal suppression but did not receive it (adjusted odds ratio, 0.3), when adjusting for demographic variables and level of family support for gender identity. "These results align with past literature, suggesting that pubertal suppression for transgender adolescents who want this treatment is associated with favorable mental health outcomes," the authors write. Turban disclosed receiving royalties from Springer for a textbook on pediatric gender identity . Explore further



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More